Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

PMVP holding history

PMV Pharmaceuticals, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PMVP overviewAll 13F holders of PMVPFull Q2 2026 holdings

Shares (Q2 2026)
361
Value
$484
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of PMVP by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026361$484<0.1%00.0%UnchangedHolders
Q1 2026361$448<0.1%−737−67.1%ReducedHolders
Q4 20251,098$1.37K<0.1%−453−29.2%ReducedHolders
Q3 20251,551$2.17K<0.1%−120,759−98.7%ReducedHolders
Q2 2025122,310$129.6K<0.1%−29,973−19.7%ReducedHolders
Q1 2025152,283$166.0K<0.1%−123,181−44.7%ReducedHolders
Q4 2024275,464$416.0K<0.1%+96,598+54.0%AddedHolders
Q3 2024178,866$266.5K<0.1%+93,963+110.7%AddedHolders
Q2 202484,903$137.5K<0.1%−48,721−36.5%ReducedHolders
Q1 2024133,624$227.2K<0.1%+5,756+4.5%AddedHolders
Q4 2023127,868$396.4K<0.1%−15,813−11.0%ReducedHolders
Q3 2023143,681$882.2K<0.1%+45,962+47.0%AddedHolders
Q2 202397,719$611.7K<0.1%+8,075+9.0%AddedHolders
Q1 202389,644$427.6K<0.1%−194,744−68.5%ReducedHolders
Q4 2022284,388$2.47M<0.1%+164,543+137.3%AddedHolders
Q3 2022119,845$1.43M<0.1%−230,465−65.8%ReducedHolders
Q2 2022350,310$4.99M<0.1%+161,299+85.3%AddedHolders
Q1 2022189,011$3.94M<0.1%+60,104+46.6%AddedHolders
Q4 2021128,907$2.98M<0.1%+32,869+34.2%AddedHolders
Q3 202196,038$2.86M<0.1%+94,956+8,776.0%AddedHolders
Q2 20211,082$37.0K<0.1%−11,857−91.6%ReducedHolders
Q1 202112,939$426.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.